A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UK.
- Published in:
- 2007
- By:
- Publication type:
- commentary
Works matching IS 11707690 AND DT 2007 AND VI 25 AND IP 9
Results: 9
1
2
The increasingly complex fourth hurdle for pharmaceuticals.
- Published in:
- 2007
- By:
- Publication type:
- journal article
3
The Authors' Reply.
- Published in:
- 2007
- By:
- Publication type:
- Letter
4
Preferences of community pharmacists for extended roles in primary care: a survey and discrete choice experiment.
- Published in:
- 2007
- By:
- Publication type:
- journal article
5
Long-term clopidogrel therapy in patients receiving percutaneous coronary intervention.
- Published in:
- 2007
- By:
- Publication type:
- journal article
6
Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature.
- Published in:
- 2007
- By:
- Publication type:
- journal article
7
Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis.
- Published in:
- 2007
- By:
- Publication type:
- journal article
8
Reliability of medicaid claims versus medical record data: in a cost analysis of palivizumab.
- Published in:
- 2007
- By:
- Publication type:
- journal article
9
Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.
- Published in:
- 2007
- By:
- Publication type:
- journal article